| [1] | YANG Xuyun, SUN Yang, TIAN Chunhua, HU Zengyao. 
														
															A National Pharmacovigilance Management System in a New Era
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 276-281. | 
																																																																																
													| [2] | SUN Yixin, WANG Chen, YU Yuelin, GUO Peng, NIE Xiaolu. 
														
															Safety Surveillance for Vaccine-Induced Immune Thrombotic Thrombocytopenia: a Systematic Review
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 29-36. | 
																																																																																
													| [3] | HOU Tiantian, WANG Xudong, YANG Ping, ZHOU Pengbo, QIN Chao, HUANG Ying, WANG Ailing, GENG Xingchao, ZHOU Xiaobing, LIU Defang. 
														
															Biodistribution of Therapeutic DNA Vaccines in Mice
														[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 58-66. | 
																																																																																
													| [4] | XIA Lanfang, LI Keli, WANG Lei, LI Yan, WANG Huaqing. 
														
															Impact of comparator selection on signal detection in adverse events following immunization in China
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 798-804. | 
																																																																																
													| [5] | LIU Yan, AN Jing, JIAO Yongzhuo, LIANG Xuefeng, ZHANG Xiaoshu. 
														
															Simple febrile seizures within 30 days of vaccination with the measles, mumps and rubella combined attenuated live vaccine in U-12 children in the real world
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 805-810. | 
																																																																																
													| [6] | NIE Xiaolu, MA Jingyao, SUN Feng, ZHAN Siyan. 
														
															Pathogenesis and diagnosis of drug-induced thrombocytopenia
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 829-835. | 
																																																																																
													| [7] | WU Yi, HE Jinyang, WANG Xiaojian, ZhOU Xiaozhu, LIU Ranjia, GUO Mingxing, ZHAO Ying, DAI Wendi, CUI Xiangli. 
														
															Adverse events of COVID-19 vaccination in recipients of liver and kidney transplant based on US VAERS database
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 572-579. | 
																																																																																
													| [8] | LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli. 
														
															Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427. | 
																																																																																
													| [9] | MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin. 
														
															Drug traceability coding system in China
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172. | 
																																																																																
													| [10] | GAO Xu, PENG Jin’e, LI Xingwang, ZHANG Wei. 
														
															Recent research of antiviral drugs and vaccines for Mpox
														[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 111-116. | 
																																																																																
													| [11] | YUAN Sisi, WANG Guangyan, LI Yifan, LI Ruilian, DU Boran, FENG Xin. 
														
															Safety-related risk factors in clinical management of narcotics and psychotropic substances via failure mode and effect analysis
														[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1027-1030. | 
																																																																																
													| [12] | ZHU Yuanchao, ZHANG Yatong, HU Xin. 
														
															Principles and measures of medication risk management in the elderly
														[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034. | 
																																																																																
													| [13] | ZI Wenrui, YANG Qiuyue, SU Jun, XIE Jiang'an. 
														
															The research development of inoculation safety associated with licensed HPV vaccines in China
														[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 311-316. | 
																																																																																
													| [14] | ZHAO Huanhuan, SONG Jiawei, LIU Jinguang, HUANG Minghui. 
														
															One case of nephrotic syndrome caused by rabies vaccine in a 5-year-old child
														[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1303-1305. | 
																																																																																
													| [15] | WU Yunxiao, YU Yuelin, WANG Shengfeng, SUN Feng, MENG Ruogu, ZHAN Siyan. 
														
															Suitability assessment of real-world data in active post-marketing surveillance of vaccine safety
														[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1081-1089. |